A study looking at diet and exercise for people with chronic lymphocytic leukaemia (HIIT-CLL STUDY)
This study is looking at whether diet and exercise can improve the health of people with chronic lymphocytic leukaemia (CLL).
This study is looking at whether diet and exercise can improve the health of people with chronic lymphocytic leukaemia (CLL).
This trial is comparing ibrutinib with, and without, treatment breaks. It is for people that have had ibrutinib for chronic lymphocytic leukaemia before.
This trial is comparing nemtabrutinib with ibrutinib or acalabrutinib for chronic lymphocytic leukaemia (CLL) or small lymphocytic lymphoma (SLL).
This trial is looking at MK-1026 for blood cancer that has come back or following treatment that has stopped working.
This trial is comparing standard treatment with 2 newer combinations of treatment to prevent GvHD.
The aim of this study is to learn more about early stage and precancerous lymphoproliferative disorders.
This trial was for people with chronic myeloid leukaemia. It looked at adding a targeted drug to the targeted drug people were already taking.
This trial is looking at acalabrutinib to see if it can improve treatment for people with Richter’s syndrome.
This study is comparing a new drug called asciminib with bosutinib for chronic myeloid leukaemia (CML).
There are around 220 chronic myeloid leukaemia deaths in the UK every year, that's more than 4 every week (2017-2019).
Chronic myeloid leukaemia accounts for less than 1% of all cancer deaths in the UK (2017-2019).
In females in the UK, chronic myeloid leukaemia accounts for around 95 deaths every year (2017-2019).
In males in the UK, chronic myeloid leukaemia accounts for around 130 deaths every year (2017-2019).